10. Charcot-Marie-Tooth disease Clinical trials / Disease details

Clinical trials : 39 /  Drugs : 44 - (DrugBank : 9) / Drug target genes : 11 - Drug target pathways : 15

  
1 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2015-001716-36-FR
(EUCTR)		03/08/201525/06/2015LONG TERM EFFECT AND TOLERANCE OF ULIPRISTAL ACETATE IN Charcot-Marie-TOOTH DISEASE TYPE 1A (UPACOMT)LONG TERM EFFECT AND TOLERANCE OF ULIPRISTAL ACETATE IN Charcot-Marie-TOOTH DISEASE TYPE 1A (UPACOMT) - UPACOMT Charcot-Marie-Tooth disease type 1A
MedDRA version: 18.0;Level: LLT;Classification code 10008414;Term: Charcot-Marie-Tooth disease;System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]		Trade Name: elleOne
Product Name: ULIPRISTAL ACETATE		HÔPITAUX UNIVERSITAIRES DE STRASBOURGNULLNot Recruiting Female: no
Male: yes		45 Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): noFrance